Associate Director, Regulatory Affairs Strategy - General Medicine
Regeneron Pharmaceuticals
Summary
Develop regulatory strategies for assigned programs in collaboration with Regeneron's Regulatory senior management and by analysis of guidances and assessment of drug developed for similar indication to obtain approval of activities in support of Regeneron's development and marketing objectives within specified timelines.
Job description
Discover your role
Develop regulatory strategies for assigned programs in collaboration with Regeneron's Regulatory senior management and by analysis of guidances and assessment of drug developed for similar indication to obtain approval of activities in support of Regeneron's development and marketing objectives within specified timelines.
- Liaison responsible for communication with FDA and other health authorities for assigned programs
- Management of all regulatory activities associated with Regeneron drug development programs
- Participate in multidisciplinary project teams to provide regulatory guidance and communicate regulatory goals
- Provide guidance to multidisciplinary teams on the regulatory requirements to support clinical development, include preparation and maintenance of IND or CTA filings
- Oversee development of all regulatory filings in support of program
- Perform/manage critical analyses of data (clinical, preclinical and manufacturing), independently develop interpretations and conclusions
- Perform reviews of clinical protocols and of clinical and preclinical study reports with respect to clarity, completeness, and regulatory requirements
- Lead multidisciplinary teams in the authoring of regulatory communications such as regulatory briefing packages
- Accountable for ensuring the completeness and accuracy of information provided in regulatory submissions
- Supervises regulatory staff with the planning, preparation and submission of all regulatory documentation
- Management of the planning, preparation and submission of licensing applications
- Provide guidance/instruction to multidisciplinary teams on the content, format, style architecture and timing of a Biologics Licensing Application (BLA) and MAA
- Assist with the scientific writing and review of application
- Evaluate conformance with the regulatory requirements, clarity, and completeness
- Manage timelines/budgets with project management as appropriate and provide progress updates to senior management
- Continually monitor newly published FDA guidelines and international guidance documents in the context of new and ongoing development programs
- Provide training on applicable requirements for scientific staff as required
This role requires
- An MD, Ph.D., Pharm.D., or equivalent advanced degree; a relevant scientific discipline is strongly preferred
- A minimum of 10 years of pharmaceutical industry experience, at least 5 of which should include regulatory experience
- Research laboratory, process development or manufacturing experience with biotechnology products highly desirable
- Must possess excellent written and verbal communication skills
Requirements
- MD, Ph.D., Pharm.D., or equivalent advanced degree
- Relevant scientific discipline strongly preferred
- Minimum of 10 years of pharmaceutical industry experience
- At least 5 years of regulatory experience
- Research laboratory, process development or manufacturing experience with biotechnology products highly desirable
- Excellent written and verbal communication skills
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.